NDC 71202-003

Eticovo

Etanercept

Eticovo is a Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Samsung Bioepis Co., Ltd.. The primary component is Etanercept.

Product ID71202-003_d2d6f14e-fdc3-46ab-b84b-4b17d3bea8f0
NDC71202-003
Product TypeHuman Prescription Drug
Proprietary NameEticovo
Generic NameEtanercept
Dosage FormInjection, Solution
Route of AdministrationSUBCUTANEOUS
Marketing Start Date2020-10-31
Marketing CategoryBLA /
Application NumberBLA761066
Labeler NameSamsung Bioepis Co., Ltd.
Substance NameETANERCEPT
Active Ingredient Strength50 mg/mL
Pharm ClassesTumor Necrosis Factor Blocker [EPC],Tumor Necrosis Factor Receptor Blocking Activity [MoA]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Drug Details

NDC Crossover Matching brand name "Eticovo" or generic name "Etanercept"

NDCBrand NameGeneric Name
50090-3531ENBRELetanercept
50090-4490ENBRELetanercept
50090-4590ENBRELetanercept
58406-010ENBRELetanercept
58406-021ENBRELetanercept
58406-032ENBRELetanercept
58406-044ENBRELetanercept

Trademark Results [Eticovo]

Mark Image

Registration | Serial
Company
Trademark
Application Date
ETICOVO
ETICOVO
88250039 not registered Live/Pending
Samsung Bioepis Co., Ltd.
2019-01-04

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.